Leukocytes from diabetic patients kill retinal endothelial cells: Effects of berberine

Molecular Vision

Volumn 19, Issue , 2013, Pages 2092-2105

  Tian, Pei ^a   Ge, Hongyan ^a   Liu, Haitao ^b   Kern, Timothy S ^b   Du, Lingling ^a   Guan, Linan ^a   Su, Sheng ^a   Liu, Ping ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CATALASE; CD18 ANTIGEN; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL ADHESION; CELL CONTACT; CELL DEATH; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINAL ENDOTHELIAL CELL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD18; APOPTOSIS; BERBERINE; CELL ADHESION; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; FEMALE; GLUCOSE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MIDDLE AGED; NF-KAPPA B; OXIDATIVE STRESS; RETINA; SIGNAL TRANSDUCTION;

EID: 84885083936     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007; 2007:43603. [PMID: 176 41741].
2. Zheng L, Kern T. Role of nitric oxide, superoxide, peroxynitrite and poly(ADP-ribose) polymerase in diabetic retinopathy. Front Biosci 2009; 14:3974-3987. [PMID: 19273327].
3. Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011; 30:343-358. [PMID: 21635964].
4. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001; 50:1938-1942. [PMID: 1147 30 58].
5. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007; 48:3805-3811. [PMID: 17652755].
6. Berkowitz BA, Gradianu M, Bissig D, Kern TS, Roberts R. Retinal ion regulation in a mouse model of diabetic reti-nopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression. Invest Ophthalmol Vis Sci 2009; 50:2351-2358. [PMID: 19074809].
7. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis A P. A central role for inflammation in the patho-genesis of diabetic retinopathy. FASEB J 2004; 18:1450-1452. [PMID: 15231732].
8. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007; 56:337-345. [PMID: 17259 377].
9. Li G, Veenstra AA, Talahalli RR, Wang X, Gubitosi-Klug RA, Sheibani N, Kern TS. Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice. Diabetes 2012; 61:3294-3303. [PMID: 22923475].
10. Talahalli R, Zarini S, Tang J, Li G, Murphy R, Kern TS, Gubitosi-Klug RA. Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukot-rienes. J Leukoc Biol 2013; 93:135-143. [PMID: 23108096].
11. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, Luscinskas FW, Adamis AP. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 2000; 41:1153-1158. [PMID: 10752954].
12. Ji HF, Shen L. Berberine: a potential multipotent natural product to combat Alzheimer's disease. Molecules 2011; 16: 6732-6740. [PMID: 21829148].
13. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 2010; 19:1297-1307. [PMID: 20836620].
14. Wu M, Wang J, Liu LT. Advance of studies on anti-atherosclerosis mechanism of berberine. Chin J Integr Med 2010; 16:188-192. [PMID: 20473748].
15. Kulkarni SK, Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phyto-therapy research PTR 2010; 24:317-324. [PMID: 19998323].
16. Wu YH, Chuang SY, Hong WC, Lai YJ, Chang GJ, Pang JH. Berberine reduces leukocyte adhesion to LPS-stimulated endothelial cells and VCAM-1 expression both in vivo and in vitro. Int J Immunopathol Pharmacol 2012; 25:741-750. [PMID: 23058024].
17. Cheng F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX, Tao J. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 2012. [PMID: 22465347].
18. Liu WH, Hei ZQ, Nie H, Tang FT, Huang HQ, Li XJ, Deng YH, Chen SR, Guo FF, Huang WG, Chen FY, Liu PQ. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl) 2008; 121:706-712. [PMID: 18701023].
19. Nagaeva O, Bondestam K, Olofsson J, Damber MG, Mincheva-Nilsson L. An optimized technique for separation of human decidual leukocytes for cellular and molecular analyses. Am J Reprod Immunol 2002; 47:203-212. [PMID: 12069387].
20. Leal EC, Martins J, Voabil P, Liberal J, Chiavaroli C, Bauer J, Cunha-Vaz J, Ambrósio AF. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010; 59:2637-2645. [PMID: 20627932].
21. Abbitt KB, Rainger GE, Nash GB. Effects of fluorescent dyes on selectin and integrin-mediated stages of adhesion and migration of flowing leukocytes. J Immunol Methods 2000; 239:109-119. [PMID: 10821952].
22. Bahmani F, Bathaie SZ, Aldavood SJ, Ghahghaei A. Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. Mol Vis 2012; 18:439-448. [PMID: 22355255].
23. Qi HP, Wei SQ, Gao XC, Yu NN, Hu WZ, Bi S, Cui H. Urso-deoxycholic acid prevents selenite-induced oxidative stress and alleviates cataract formation: In vitro and in vivo studies. Mol Vis 2012; 18:151-160. [PMID: 22275806].
24. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179:588-590. [PMID: 4686466].
25. Tsai CF, Lu FJ, Hsu Y W. Protective effects of Dunaliella salina - a carotenoids-rich alga against ultraviolet B-induced corneal oxidative damage in mice. Mol Vis 2012; 18:1540-1547. [PMID: 22736944].
26. Zhao F, Wang L, Liu K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 2009; 122:457-462. [PMID: 19 429312].
27. Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010; 59:285-292. [PMID: 19800084].
28. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 2009; 116:902-911., quiz 12-3. [PMID: 19410949].
29. Yilmaz T, Cordero-Coma M, Gallagher MJ, Teasley LA. Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema. Acta Ophthalmol (Copenh) 2011; 89:709-717. [PMID: 20645926].
30. Silva PS, Sun JK, Aiello LP. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin Ophthalmol 2009; 24:93-99. [PMID: 19373693].
31. El-Asrar AM, Missotten L, Geboes K. Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibro-vascular epiretinal membranes. Br J Ophthalmol 2008; 92:1534-1539. [PMID: 18952655].
32. Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 2006; 17:155-165. [PMID: 17194635].
33. Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye (Lond) 2004; 18:306-313. [PMID: 15004583].
34. Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 2001; 132:551-556. [PMID: 115898 78].
35. Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 2007; 56:373-379. [PMID: 17259381].
36. Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J 2003; 17:76-8. [PMID: 12475915].
37. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10:1344-1351. [PMID: 1553188 9].
38. Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2012; 2012:591654. [PMID: 23118793].